Quality of Life Improvement in Dry Eye Patients After Intense Pulsed Light Therapy Compared to Punctal Plugs

Sponsor
Tanta University (Other)
Overall Status
Completed
CT.gov ID
NCT05331924
Collaborator
(none)
30
1
2
14
2.1

Study Details

Study Description

Brief Summary

Dry eye disease (DED) is a widely spread disorder of tears and ocular surface affecting hundreds of millions around the world. Manifestations resulting from moderate to severe DED have significant effects on the patient's quality of life (QOL). These patients may suffer pain, role limitation, sleep disorders, anxiety, and depression. QOL affection may be comparable to serious illnesses such as renal failure, angina, and disabling fractures.

Evaporative form is the commonest form of DED and it is mainly caused by meibomian glands dysfunction (MGD). The usual traditional treatment options for MGD include warm compresses, expression of meibomian glands (MG), anti-inflammatory drugs, and lubricant eye drops. In many instances, the traditional treatment with artificial tears is not effective.

Non-pharmacological intervention such as punctal occlusion was advocated in these patients. Punctal plugs are designed to block lacrimal drainage, which helps in the preservation of lubricant drops, improving the tear film quantitively and qualitatively. Intense pulsed light therapy (IPL) is another option that has been used by many investigators for the treatment of evaporative dry eye due to MGD safely and effectively.

This study was conducted to compare the improvement of patients' QOL after treatment of severe to moderate evaporative DED with IPL therapy versus silicone punctal plug insertion.

The study included 30 patients with severe to moderate evaporative dry eye secondary to MGD. The effect of DED on patients' QOL was evaluated with the aid of ocular surface disease index (OSDI) questionnaire. Fifteen patients were treated with IPL therapy. The treatment consisted of 3 sessions, with 15 days between the first and second sessions, and 30 days between the second and third sessions. And 15 patients were treated by silicone punctal plug insertion. After the completion of treatment, the Improvement of patients' QOL was evaluated by OSDI questionnaire. The results of both treatments were compared.

Condition or Disease Intervention/Treatment Phase
  • Procedure: IPL therapy
  • Procedure: Punctal plugs
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Quality of Life Improvement in Dry Eye Patients After Intense Pulsed Light Therapy Compared to Punctal Plugs
Actual Study Start Date :
Dec 1, 2020
Actual Primary Completion Date :
Dec 1, 2021
Actual Study Completion Date :
Feb 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: IPL therapy

Fifteen patients with severe to moderate evaporative dry eye disease were treated with 3 sessions of IPL therapy.

Procedure: IPL therapy
Intense pulsed light therapy (IPL) is a non-coherent large wavelength high-intensity light in the range of 500-1200nm. It has been used by many investigators for the treatment of evaporative dry eye safely and effectively.

Active Comparator: Punctal plugs

Fifteen patients with severe to moderate evaporative dry eye disease were treated with silicone punctal plug insertion.

Procedure: Punctal plugs
Silicone punctal plugs are small pieces of silicone designed to block tear drainage through occluding the lacrimal punctum.

Outcome Measures

Primary Outcome Measures

  1. Patient's quality of life (QOL) affection. [before treatment]

    The effect of dry eye on the patient's Quality Of Life (QOL) was evaluated with the aid of the Ocular Surface Disease Index (OSDI) questionnaire. A score of 33 or more indicated severe affection, 23 to 33 indicated moderate, 13 to 22 mild, while 12 or less represented the normal range.

  2. Change in patient's quality of life (QOL) affection. [Within 1 month after completion of treatment]

    The effect of dry eye on the patient's Quality Of Life (QOL) was evaluated with the aid of the Ocular Surface Disease Index (OSDI) questionnaire. A score of 33 or more indicated severe affection, 23 to 33 indicated moderate, 13 to 22 mild, while 12 or less represented the normal range.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • MGD patients with moderate to severe evaporative dry eye.

  • Patients older than 18 years old.

Exclusion Criteria:
  • Patients with dry eye due to auto-immune disorders. e.g.: Sjogren syndrome.

  • Patients with conjunctival cicatrizing diseases. e.g.: ocular cicatricial pimphegoid.

  • Patients with mild dry eye.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Faculty of Medicine, Tanta University Tanta Egypt

Sponsors and Collaborators

  • Tanta University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Molham Abdelhafez Elbakary, Assistant professor of Ophthalmology, Tanta University
ClinicalTrials.gov Identifier:
NCT05331924
Other Study ID Numbers:
  • 35345/3/22
First Posted:
Apr 18, 2022
Last Update Posted:
Apr 18, 2022
Last Verified:
Apr 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Molham Abdelhafez Elbakary, Assistant professor of Ophthalmology, Tanta University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 18, 2022